False positive amphetamines and 3, 4-methylenedioxymethamphetamine immunoassays in the presence of metoprolol—two cases reported in clinical toxicology

M Leclercq, M Soichot… - Journal of Analytical …, 2020 - academic.oup.com
Amphetamines, frequently used recreational drugs with high risk of toxicity, are commonly
included in urine drug screens. This screening is based on enzyme immunoassay, which is …

The Trazodone Metabolite meta-Chlorophenylpiperazine Can Cause False-Positive Urine Amphetamine Immunoassay Results

JM Baron, DA Griggs, AL Nixon… - Journal of Analytical …, 2011 - academic.oup.com
Amphetamines and methamphetamines are part of an important class of drugs included in
most urine drugs of abuse screening panels, and a common assay to detect these drugs is …

False-positive amphetamines in urine drug screens: a 6-year review

JD Pope, OH Drummer… - Journal of Analytical …, 2023 - academic.oup.com
Immunoassays are routinely used to provide rapid urine drug screening results in the clinical
setting. These screening tests are prone to false-positive results and ideally require …

ELISA Detection of 30 New Amphetamine Designer Drugs in Whole Blood, Urine and Oral Fluid using Neogen® “Amphetamine” and “Methamphetamine/MDMA” Kits

M Nieddu, L Burrai, E Baralla, V Pasciu… - Journal of Analytical …, 2016 - academic.oup.com
Amphetamine designer drugs are central nervous system stimulants that are widely
disseminated in the illegal market. Generally, in forensic laboratories, immunoassay …

[HTML][HTML] Cross-reactivities of 41 new amphetamine designer drugs to EMIT® immunoassays

M Nieddu, C Trignano, L Burrai, MA Pirisi, G Boatto - Forensic Toxicology, 2013 - Springer
Amphetamine designer drugs are central nervous system stimulants, and are widely diffused
in illegal markets. Monitoring of drugs of abuse in biological fluids is successfully used for …

Lack of detection of new amphetamine-like drugs using conventional urinary immunoassays

A Begeman, EJF Franssen - Therapeutic Drug Monitoring, 2018 - journals.lww.com
Background: The number of reports of serious adverse effects and intoxication after the use
of the new drug 4-fluoroamphetamine (4-FA) increases. At the Emergency Department of the …

Detectability of new psychoactive substances,'legal highs', in CEDIA, EMIT, and KIMS immunochemical screening assays for drugs of abuse

O Beck, L Rausberg, Y Al‐Saffar, T Villen… - Drug testing and …, 2014 - Wiley Online Library
The increasing number of new psychoactive substances made available for recreational
drug use has created a challenge for clinical toxicology and drug testing laboratories. As a …

The missing metabolite: how unexpected urine drug metabolite patterns may lead to false interpretations

A Hutcherson Wright, JA Young, B Elise Smith… - Clinical …, 2018 - academic.oup.com
A 31-year-old pregnant woman at 25-week gestation was admitted for preterm premature
rupture of membranes and subsequently delivered preterm at 29 weeks. The patient insisted …

Determination of designer drug cross-reactivity on five commercial immunoassay screening kits

LE Regester, JD Chmiel, JM Holler… - Journal of analytical …, 2015 - academic.oup.com
The detection of new designer drugs is often a difficult issue in forensic urine drug testing as
immunoassays are the primary screening methodology for drugs of abuse in many of these …

Drug testing in the era of new psychoactive substances

RR Gerona, D French - Advances in Clinical Chemistry, 2022 - Elsevier
Traditional clinical toxicology involves the analysis of patient urine samples by
immunoassays designed to detect opiates/opioids, amphetamine/methamphetamine …